Is Serum IL-17A a Useful Systemic Biomarker in Patients With Langerhans Cell Histiocytosis?

Molecular Therapy - United States
doi 10.1038/mt.2011.239
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Langerhans Cell Histiocytosis

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2020English

Langerhans Cell Histiocytosis

English

Langerhans Cell Histiocytosis: A Case Report

Serbian Journal of Dermatology and Venereology
Dermatology
2013English

Pulmonary Langerhans Cell Histiocytosis Associated With Hodgkin's Lymphoma

European Respiratory Review
PulmonaryRespiratory Medicine
2010English

Langerhans Cell Histiocytosis in an Adult Patient

Vestnik dermatologii i venerologii
2019English

A Case of Langerhans Cell Histiocytosis With Atypical Radiological Presentation

Turkish Thoracic Journal
PulmonaryRespiratory Medicine
2015English

Langerhans Cell Histiocytosis in Adults Is Associated With Increased Hematologic and Solid Malignancies

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

IL-17A Softens the Skin: Antifibrotic Properties of IL-17A in Systemic Sclerosis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2020English

Bone Scintigraphy in the Examining of Treatment-Naive Pediatric Patients With Langerhans Cell Histiocytosis

Journal of oncology: diagnostic radiology and radiotherapy
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy